Here’s a comma-separated list of tags for the post title: Drug Development

On March 26, 2025, the U.S. Food and Drug Administration (FDA) approved Vykat XR (diazoxide choline) extended-release tablets, developed by Soleno Therapeutics, as the first treatment for hyperphagia in individuals …